According to an article posted in Dermatology Daily, from the American Academy of Dermatology, reports that a new vaccine from Amgen called TVEC, which harnesses the power of a patient’s own immune system, appears to have some effect in controlling melanoma on a local basis when injected directly into a lesion on or under the skin or in a lymph node, according to data gleaned from an ongoing Phase III clinical trial. However, it remains to be seen whether the vaccine would be efficacious for the treatment of melanoma metastases to the lungs, brain or liver, according to Dr. Robert Kaufman, director of the Rush University Cancer Center at Rush University Medical Center, Illinois.

Source: Dermatology Daily, The Financial Times /Biopharm (8/31, Livoti, Subscription Publication)